GGrantIndex
← Leaderboards

Morgan Erika Grams

New York University School Of Medicine

$12,889,441
Attributed
$22,868,467
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.6M · FY201225
$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$22,868,467 · 7

By mechanism

R01$21,484,929 · 5
K08$792,688 · 1
K24$590,850 · 1

Top collaborators

Most similar at New York University School Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Chronic Kidney Failure

Research focus

Chronic Kidney FailureCohortRenal FunctionKidneyKidney DiseasesParticipantDisease ProgressionAlbuminuriaEnd Stage Renal FailureDesignGlomerular Filtration RateHypertensionCaringGuidelinesHigh RiskMortalityFundingEvaluationPreventionResearch PersonnelCessation Of LifeInnovationGrantCardiovascular Diseases

Grant awards (42)

Chronic Kidney Disease Prognosis Consortium (CKD-PC)$854,984
R01 · FY2025 · DK
Optimizing Preimplantation Kidney Transplant Biopsy Interpretation with Artificial Intelligence Assistance - Resubmission - 1$734,376
R01 · FY2025 · DK
Maximizing The Benefit of Therapy in CKD$692,438
R01 · FY2025 · DK · contact PI
Multi-Omics and Chronic Kidney Disease: Correlation with Histology$667,051
R01 · FY2025 · DK · contact PI
Optimizing Preimplantation Kidney Transplant Biopsy Interpretation with Artificial Intelligence Assistance - Resubmission - 1$157,276
R01 · FY2025 · DK
Prevention and Treatment of Cardiovascular Disease in Patients with Chronic Kidney Disease: Patient-Oriented Research and Mentoring$118,170
K24 · FY2025 · HL · contact PI
Chronic Kidney Disease Prognosis Consortium (CKD-PC)$835,918
R01 · FY2024 · DK
Optimizing Preimplantation Kidney Transplant Biopsy Interpretation with Artificial Intelligence Assistance - Resubmission - 1$735,047
R01 · FY2024 · DK
Maximizing The Benefit of Therapy in CKD$670,156
R01 · FY2024 · DK · contact PI
Integrative Omics, Chronic Kidney Disease, and Adverse Outcomes in Older Adults$640,990
R01 · FY2024 · DK · contact PI
Multi-Omics and Chronic Kidney Disease: Correlation with Histology$640,290
R01 · FY2024 · DK · contact PI
Prevention and Treatment of Cardiovascular Disease in Patients with Chronic Kidney Disease: Patient-Oriented Research and Mentoring$118,170
K24 · FY2024 · HL · contact PI
Chronic Kidney Disease Prognosis Consortium (CKD-PC)$843,137
R01 · FY2023 · DK
Maximizing The Benefit of Therapy in CKD$755,030
R01 · FY2023 · DK · contact PI
Multi-Omics and Chronic Kidney Disease: Correlation with Histology$713,017
R01 · FY2023 · DK · contact PI
Prevention and Treatment of Cardiovascular Disease in Patients with Chronic Kidney Disease: Patient-Oriented Research and Mentoring$118,170
K24 · FY2023 · HL · contact PI
Chronic Kidney Disease Prognosis Consortium (CKD-PC)$99,921
R01 · FY2023 · DK
Multi-Omics and Chronic Kidney Disease: Correlation with Histology$762,855
R01 · FY2022 · DK · contact PI
Integrative Omics, Chronic Kidney Disease, and Adverse Outcomes in Older Adults$721,316
R01 · FY2022 · DK · contact PI
Chronic Kidney Disease Prognosis Consortium$708,858
R01 · FY2022 · DK
Prevention and Treatment of Cardiovascular Disease in Patients with Chronic Kidney Disease: Patient-Oriented Research and Mentoring$118,170
K24 · FY2022 · HL · contact PI
Medication Use and Adverse Events in CKD$724,632
R01 · FY2021 · DK · contact PI
Chronic Kidney Disease Prognosis Consortium$716,870
R01 · FY2021 · DK
Integrative Omics, Chronic Kidney Disease, and Adverse Outcomes in Older Adults$687,667
R01 · FY2021 · DK · contact PI
Prevention and Treatment of Cardiovascular Disease in Patients with Chronic Kidney Disease: Patient-Oriented Research and Mentoring$118,170
K24 · FY2021 · HL · contact PI
Chronic Kidney Disease Prognosis Consortium$724,883
R01 · FY2020 · DK
Medication Use and Adverse Events in CKD$719,054
R01 · FY2020 · DK · contact PI
Integrative Omics, Chronic Kidney Disease, and Adverse Outcomes in Older Adults$718,068
R01 · FY2020 · DK · contact PI
Metabolomics and Genomics in African Americans with CKD$576,775
R01 · FY2020 · DK · contact PI
Chronic Kidney Disease Prognosis Consortium$732,893
R01 · FY2019 · DK
Medication Use and Adverse Events in CKD$726,256
R01 · FY2019 · DK · contact PI
Metabolomics and Genomics in African Americans with CKD$577,734
R01 · FY2019 · DK · contact PI
Chronic Kidney Disease Prognosis Consortium$752,562
R01 · FY2018 · DK
Medication Use and Adverse Events in CKD$752,537
R01 · FY2018 · DK · contact PI
Metabolomics and Genomics in African Americans with CKD$602,942
R01 · FY2018 · DK · contact PI
Metabolomics and Genomics in African Americans with CKD$603,861
R01 · FY2017 · DK · contact PI
Metabolomics and Genomics in African Americans with CKD$635,535
R01 · FY2016 · DK · contact PI
The comparative effectiveness of kidney transplantation in advanced CKD$158,668
K08 · FY2016 · DK · contact PI
The comparative effectiveness of kidney transplantation in advanced CKD$158,668
K08 · FY2015 · DK · contact PI
The comparative effectiveness of kidney transplantation in advanced CKD$158,668
K08 · FY2014 · DK · contact PI
The comparative effectiveness of kidney transplantation in advanced CKD$158,668
K08 · FY2013 · DK · contact PI
The comparative effectiveness of kidney transplantation in advanced CKD$158,016
K08 · FY2012 · DK · contact PI